广西医学
廣西醫學
엄서의학
GUANGXI MEDICAL JOURNAL
2014年
8期
1083-1085
,共3页
唐国全%沙慧芳%唐玉竺
唐國全%沙慧芳%唐玉竺
당국전%사혜방%당옥축
鼻咽癌%EB病毒%Rta-IgG抗体%酶联免疫吸附法%诊断
鼻嚥癌%EB病毒%Rta-IgG抗體%酶聯免疫吸附法%診斷
비인암%EB병독%Rta-IgG항체%매련면역흡부법%진단
Nasopharyngeal carcinoma%Epstein-Barr virus%Rta-IgG%Enzyme-linked immunosorbent assay%Diagnosis
目的:探讨血清EB病毒Rta蛋白抗体IgG( Rta-IgG)诊断鼻咽癌的价值。方法未经治疗的鼻咽癌患者和健康体检者各150例,采用酶联免疫吸附法检测血清Rta-IgG抗体,应用受试者工作特征( ROC )曲线对结果进行分析评价。结果150例鼻咽癌患者血清Rta-IgG抗体阳性134例(89.3%),150例健康对照组血清Rta-IgG抗体阳性17例;血清Rta-IgG抗体诊断鼻咽癌的敏感度为89.3%,特异性为88.6%。结论检测血清EB病毒Rta-IgG抗体诊断鼻咽癌有较高的临床价值。
目的:探討血清EB病毒Rta蛋白抗體IgG( Rta-IgG)診斷鼻嚥癌的價值。方法未經治療的鼻嚥癌患者和健康體檢者各150例,採用酶聯免疫吸附法檢測血清Rta-IgG抗體,應用受試者工作特徵( ROC )麯線對結果進行分析評價。結果150例鼻嚥癌患者血清Rta-IgG抗體暘性134例(89.3%),150例健康對照組血清Rta-IgG抗體暘性17例;血清Rta-IgG抗體診斷鼻嚥癌的敏感度為89.3%,特異性為88.6%。結論檢測血清EB病毒Rta-IgG抗體診斷鼻嚥癌有較高的臨床價值。
목적:탐토혈청EB병독Rta단백항체IgG( Rta-IgG)진단비인암적개치。방법미경치료적비인암환자화건강체검자각150례,채용매련면역흡부법검측혈청Rta-IgG항체,응용수시자공작특정( ROC )곡선대결과진행분석평개。결과150례비인암환자혈청Rta-IgG항체양성134례(89.3%),150례건강대조조혈청Rta-IgG항체양성17례;혈청Rta-IgG항체진단비인암적민감도위89.3%,특이성위88.6%。결론검측혈청EB병독Rta-IgG항체진단비인암유교고적림상개치。
Objective To explore the diagnostic value of Rta-IgG of Epstein-Barr virus(EBV) in nasopharyngeal carcinoma(NPC) patients.Methods Enzyme-linked immunosorbent assay was applied to detecting the level of serum Rta-IgG in 150 untreated patients with NPC and 150 healthy controls,respectively.Receiver operating characteristic (ROC) curve was applied to the data analysis .Results The positive numbers in 150 untreated patients with NPC and 150 controls were 134(89.3%) and 17,respectively.The sensitivity of the assay was 89.3%and the specificity was 88.6%.Conclusion The detection of serum Rat-IgG is clinically beneficial in the diagnosis of NPC .